The correct formation of disulfide bonds in the periplasm of Escherichia coli involves Dsb proteins, including two related periplasmic disulfide-bond isomerases, DsbC and DsbG. DsbD is a membrane protein required to maintain the functional oxidation state of DsbC and DsbG. In this work, purified proteins were used to investigate the interaction between DsbD and DsbC. A 131-residue N-terminal fragment of DsbD (DsbD␣) was expressed and purified and shown to form a functional folded domain. Gel filtration results indicate that DsbD␣ is monomeric. DsbD␣ was shown to interact directly with and to reduce the DsbC dimer, thus increasing the isomerase activity of DsbC. The DsbC-DsbD␣ complex was characterized, and formation of the complex was shown to require the N-terminal dimerization domain of DsbC. These results demonstrate that DsbD interacts directly with full-length DsbC and imply that no other periplasmic components are required to maintain DsbC in the functional reduced state.
T
he best understood system for the formation of disulfide bonds in folding proteins occurs in the periplasm of Gramnegative bacteria. In Escherichia coli, protein disulfide-bond formation depends on the products of dsb genes which contain active-site disulfides and are members of the thioredoxin protein superfamily. Five Dsb proteins, DsbA (1, 2), DsbB (3, 4) , DsbC (5, 6) , DsbD (7) , and DsbG (8) , have been shown to be involved in disulfide-bond formation and rearrangement. Significant progress has been made in understanding how these proteins interact and function in the periplasm. A search of protein sequence databases revealed that homologs of E. coli Dsb proteins occur in many Gram-negative bacteria including early branching thermophiles, suggesting that the system for disulfidebond formation in the periplasm is widely conserved.
The addition of disulfide bonds within the periplasm is a rapid, nonspecific process (9, 10) catalyzed by the soluble periplasmic protein DsbA (1) . DsbA adds disulfide bonds to newly synthesized substrate proteins by donating its active-site disulfide bond (1, 2) . Electrons generated by the formation of substrate disulfide bonds are transferred to the DsbA active-site sulfhydryls. The active site of DsbA is regenerated by the transfer of electrons to the integral membrane protein DsbB (4, (11) (12) (13) (14) (15) (16) which, in turn, passes electrons to quinone and the electron transport chain (17) (18) (19) (20) . Incorrect disulfide bonds formed by DsbA may trap proteins in nonnative conformations (10, 21) . Disulfide-bond isomerases catalyze the rearrangement of disulfide bonds, allowing proteins trapped by incorrect disulfide bonds to fold correctly. Two homologous enzymes, DsbC and DsbG, facilitate folding of proteins with multiple disulfide bonds in the periplasm (5, 6, 8) . Both enzymes are homodimers with protein disulfide-bond isomerase activity (22, 23) . The ability of DsbC and DsbG to rearrange incorrect disulfide bonds requires that the active-site cysteines be maintained in the reduced form (24) , and both are found almost exclusively in this form in the periplasm (25, 26) . The integral membrane protein DsbD transports electrons across the inner membrane of E. coli from cytoplasmic thioredoxin (25) (26) (27) (28) (29) (30) to the periplasmic target proteins DsbC and DsbG, as well as to the cytochrome c biosynthesis pathway via CcmG (also known as DsbE; refs. [28] [29] [30] . Cells lacking either thioredoxin or DsbD accumulate DsbC and DsbG in the inactive oxidized form (25, 27) .
The requirement for the DsbC and DsbG active sites to be reduced raises the question of how this reduction occurs in the oxidizing periplasmic environment. Recent in vivo evidence suggests that DsbD does transfer electrons directly to DsbC (30, 31) . Apparently, electrons are transferred specifically to the active-site disulfide bonds of oxidized DsbC, DsbG, and CcmG, avoiding the many other disulfide bonds in the periplasm. Little is known about how this specificity is achieved.
The recently determined crystal structure of DsbC revealed a V-shaped homodimer where each DsbC monomer is arranged into two distinct domains ( Fig. 1A; ref. 32 ). Residues 78-216, including the CGYC active-site motif (residues 98-101), fold into a domain with a three-dimensional structure similar to that of thioredoxin. The active sites of the thioredoxin domains from each DsbC monomer face inwards across a broad uncharged cleft thought to be the site where folding substrate proteins bind to the molecule. Each of the two thioredoxin domains is connected by a hinged ␣-helical stalk to a separate central dimerization domain consisting of the N-terminal 65 aa of each 216-residue DsbC monomer (32) . Both active sites of the DsbC dimer are required for isomerase activity; the thioredoxin domain alone is inactive (33) .
DsbD is arranged into three domains (28, 30) : DsbD␣, DsbD␤, and DsbD␥ (Fig. 1B) . DsbD␣ forms a periplasmic domain of 131 residues containing two of the six essential cysteines (C103 and C109) found in DsbD. The central transmembrane domain, DsbD␤ (residues 132-429), contains eight predicted transmembrane segments and includes two essential cysteines, C163 in the first transmembrane segment and C285 in the fourth (28, 29) . The remaining 135 residues form a second periplasmic domain (DsbD␥) with significant homology to thioredoxin, including a thioredoxin-like active-site motif (CVAC, residues 480-483). Coexpression of all three domains individually restores function to a DsbD-null strain, showing them to function as separate modules (30) . Experiments involving the expression of DsbD mutants with systematically mutated cysteines revealed the formation of mixed disulfides between thioredoxin and C163 of DsbD␤ and between C98 of DsbC and C109 of DsbD␣ (30, 31) . The latter complex could be observed in cells expressing the mutants DsbC C101A and DsbD C103A (31) . These results provide evidence that thioredoxin interacts directly with the central domain of DsbD, and that the Nterminal domain of DsbD interacts directly with DsbC. Katzen and Beckwith (30) have proposed a mechanism in which electrons are accepted from cytoplasmic thioredoxin by DsbD␤. Electrons are thought to pass through the membrane to DsbD␥ and then to DsbD␣ before the reduction of periplasmic targets (30) .
Here, we show that the first periplasmic domain of DsbD (DsbD␣) is able to form a functional domain, and that it is responsible for the final crucial step in activating the periplasmic disulfide-bond isomerase DsbC by reducing its active-site disulfide bond. We prepared the DsbD␣-DsbC mixed disulfide complex by using the purified single-cysteine mutants DsbD␣ C103A and DsbC C101A. Finally, we analyzed the stoichiometry of the complex and showed that complex formation with the thioredoxin domain of DsbC alone does not occur, suggesting that the DsbD␣-DsbC interaction requires the complete DsbC molecule.
Methods
Cloning of DsbCC101S-pET22b. DsbC with the active-site mutation C101S was generated by site-directed mutagenesis using the primers pETT7-f (5Ј-CAC TAT AGG GGA ATT GTG AGC GG-3Ј), DsbCC121S-f (5Ј-CC TGT GGT TAC TCC CAC AAA CTG C-3Ј), DsbCC121S-R (5Ј-CAG TTT GTG GGA GTA ACC ACA GG-3Ј), and pETT7-R (5Ј-CTA GTT ATT GCT CAG CGG TGG CAG C-3Ј).
DNA coding for the C-terminal thioredoxin-like domain of DsbC lacking the N-terminal dimerization domain (DsbC⌬N63 and DsbC⌬N63 C101S) was amplified from full-length DsbC and DsbC C101S by using the primers DsbC⌬N63-f (5Ј-GTC AAT GCC ATG GAT AAG ATG CTG-3Ј) and pETT7-R. The PCR fragment was digested with NcoI͞BamHI and ligated into linearized pProEX-HTa.
A fragment encoding DsbD␣ was amplified by PCR from pFK051 (30) by using the primers PQE30 (5Ј-GAG GGA TCC GAA AAC CTG TAC TTC CAG TCA GGA TTA TTC GAC GCG CCG GGA CGT TCA CAA-3Ј) and BADREV (5Ј-ACC GCT TCT GCG TTC TGA TT-3Ј). The amplified fragment was digested with the enzymes BamHI and HindIII, and cloned into linearized pQE-30 vector (Qiagen, Chatsworth, CA). The resulting construct pFK115 encodes a cytoplasmic variant of DsbD␣ peptide in which the signal sequence was replaced by a His 6 tag followed by a tobacco etch virus cleavage site. To generate DsbD␣ C103A, the codon specifying the first active cysteine of DsbD␣ was exchanged with that one encoding alanine by using the QuickChange Site-Directed Mutagenesis Kit (Stratagene).
All constructs were verified by DNA sequencing.
Protein Expression and Purification. DsbC was expressed from the plasmid DsbC-pET22b in BL21 (DE3) cells (34), prepared as described (32) by osmotic shock, and purified by anion-exchange chromatography with a Q-Sepharose Fast-Flow column (Amersham Pharmacia) equilibrated with 50 mM Bis-Tris⅐HCl at pH 6.5. DsbC eluted in a 0-0.4 M NaCl gradient as a single peak, and purity was confirmed by Coomassie blue-stained SDS gels. DsbC C101S was expressed and purified as described for DsbC, except that DsbC C101S was purified in a NaCl gradient on a Q-Sepharose Fast-Flow anion exchange column equilibrated with 50 mM Tris⅐HCl at pH 6.8.
DsbD␣ and DsbD␣ C103A were expressed in DH5␣ (Z1) cells (35) . Cells were grown overnight to saturation (at 37°C) and induced (at 28°C and 37°C, respectively) with 1 mM isopropyl ␤-D-thiogalactoside (IPTG). Cells were harvested and lysed by French press; cell lysate was centrifuged at 16,000 ϫ g for 30 min to remove cellular debris. Glutathione disulfide (GSSG) was added to a final concentration of 100 M to ensure that DsbD␣ was in the oxidized form. Protein was purified by immobilized metal-affinity chromatography on a 5 ml High Trap Chelating column (Amersham Pharmacia) with bound Ni 2ϩ equilibrated with 50 mM Hepes, pH 8.0͞300 mM NaCl. Both proteins were eluted with 200 mM imidazole. SDS͞PAGE showed DsbD␣ and DsbD␣ C103A to be essentially pure. DsbC⌬N63 was expressed as described for DsbC and purified by immobilized metal-affinity chromatography as described for DsbD␣. DsbC⌬N63 was eluted with 250 mM imidazole.
Redox Interactions Between DsbC and DsbD␣. DsbC was incubated in 10 mM DTT for 30 min at room temperature to reduce the active-site cysteines. Excess DTT was removed by passage over a PD-10 column (Amersham Pharmacia) equilibrated with 0.1 M sodium phosphate, pH 7.5͞1 mM EDTA. DsbD␣ and DsbD␣ C103A were reduced as described above by using 50 mM DTT. The number of free cysteines of native and denatured proteins was monitored before and after reduction by using DTNB (Ellman's reagent, 5,5Ј-dithiobis(2-nitrobenzoic acid; ref. 36) . Reduced protein samples were stored at 4°C.
Disulfide exchange between DsbC and DsbD␣ was investigated by alkylation with 4-acetamido-4Ј-maleimidylstilbene-2,2Ј-disulfonic acid (AMS; Molecular Probes). Oxidized and reduced proteins at a final concentration of 10 M were incubated at 37°C for 90 min in 100 mM sodium phosphate, pH 7.5͞1 mM EDTA. Proteins were precipitated and disulfide-exchange reactions were quenched by the addition of trichloroacetic acid (TCA) to a final concentration of 10% for 30 min at 0°C. After centrifugation (16,000 ϫ g for 10 min at 4°C), the pellet was residues form a periplasmic domain (DsbD␣) followed by eight transmembrane segments (DsbD␤) and a second periplasmic domain thought to be a thioredoxin-like fold (DsbD␥). The first 19 aa are not shown, as these form a cleavable signal sequence that is removed upon insertion into the membrane.
resuspended in 1 M Tris⅐HCl, pH 8.0͞1 mM EDTA͞1% SDS͞10 mM AMS (Molecular Probes) and incubated for 90 min at 37°C. Proteins were reprecipitated with 1 ml of ice-cold acetone and pelleted. The pellet was resuspended in nonreducing Laemmli buffer and heated for 5 min at 96°C before separation by SDS͞15% PAGE. Isomerase assay. Protein Samples of 2 M were incubated with 5 M sRNase A in 0.1 M sodium phosphate buffer, pH 7.5͞1 mM EDTA adjusted to a final volume of 1 ml. After 2 hr at room temperature, 4.5 mM cytidine 2Ј,3Ј-cyclic monophosphate (cCMP) was added, and RNase A activity was determined by measuring absorbance at 296 nm over 20 min.
Complex Formation Between DsbD␣ C103A and DsbC. DsbC and DsbD␣ proteins were mixed at ratios of 1:2 (0.2 mM ϩ 0.4 mM) in the absence of any redox reagent or in the presence of either 20 mM GSSG as oxidant or 20 mM DTT as reductant. The protein mixtures were incubated at room temperature for at least 1 hr. Samples of 100 l each were analyzed by gel filtration followed by peak analysis on reducing and nonreducing SDS͞ PAGE.
Complex formation between DsbD␣ and DsbC was determined by molecular-weight analysis. Gel filtration chromatography was used to estimate the molecular masses of native and mutant proteins and complexes. All experiments were carried out in 50 mM Tris⅐HCl, pH 8.0͞200 mM NaCl by using a Superdex 75 HR0͞30 gel filtration column (Amersham Pharmacia) on an Ä KTA Explorer FPLC System (Amersham Pharmacia) at a flow rate of 1.5 ml͞min.
The column was calibrated with the low molecular weight gel filtration calibration kit from Amersham Pharmacia.
Determination of Protein Concentration. All protein concentrations were determined by UV absorption at 280 nm by using the following calculated (37) . All concentrations were calculated for monomeric protein.
Results

DsbD␣ Forms a Soluble Monomeric Domain with Both Cysteines
Exposed. To obtain the isolated ␣-domain of DsbD, a construct (DsbD␣) containing residues 1-131 of DsbD and preceded by an N-terminal His 6 tag and a nine-residue flexible linker segment containing a tobacco etch virus (TEV) protease cleavage site was expressed and purified from total cell lysate under oxidizing conditions (100 M GSSG) by immobilized metal-affinity chromatography. Subsequent experiments demonstrated that the protein was active without removal of the N-terminal extension; therefore, the TEV protease cleavage site was not used (data not shown). The purified DsbD␣ protein could be concentrated to at least 20 mg͞ml without aggregation. The apparent molecular mass estimated from SDS͞PAGE was Ϸ18 kDa, consistent with the calculated value from the DNA sequence (17.1 kDa). The molecular mass of native DsbD␣ was estimated by comparison with known standards by using gel filtration chromatography. Both DsbD␣ and DsbD␣ C103A eluted with an apparent molecular mass of 25 kDa (K av ϭ 0.25), confirming that they are monomeric in solution and suggesting a somewhat extended conformation (increased apparent molecular masses are expected for nonspherical molecules).
DsbD␣ and DsbD␣ C103A were reduced by using 50 mM DTT and the resultant free thiol molar ratio was estimated by using DTNB (Ellman's reagent). Both cysteine residues of DsbD␣ were accessible (1.6 thiol per mol) as was C109 of the single-cysteine mutant DsbD␣ C103A (0.6 thiols per mol). The redox status of DsbD␣ was also investigated by using AMS, an Ϸ500-Da reagent that covalently labels free thiols. Proteins were fixed and denatured with 10% (vol͞vol) TCA before AMS labeling and analyzed under nonreducing conditions with SDS͞ PAGE. The bound AMS caused a visible shift in mobility. Reduced and oxidized DsbD␣, as also DsbD␣ C103A, migrate as single bands, and AMS band-shifts were observed that clearly distinguished all three molecules (Fig. 2) .
DsbD␣ Reduces DsbC. When reduced DsbD␣ and oxidized DsbC were mixed, both proteins showed redox changes consistent with quantitative disulfide-bond transfer from DsbC to DsbD␣ (Fig.  2, lane c) . Equal amounts of oxidized DsbD␣ and reduced DsbC were observed as expected for the transfer of electrons from one DsbD␣ molecule to one DsbC monomer. The presence of some remaining oxidized DsbC suggests that the reaction had proceeded to completion and that no remaining reduced DsbD␣ was present to reduce DsbC. No shift in redox state was observed in the reverse reaction when reduced DsbC was mixed with oxidized DsbD␣ (Fig. 2, lane g) . No evidence of the mixed disulfide complex between DsbC and DsbD␣ was observed after trapping with TCA.
DsbD␣ Activates DsbC. The disulfide-bond isomerase activity of DsbC was assessed to determine whether DsbC is activated after reduction by DsbD␣. Disulfide-bond isomerase activity was assayed by measuring the recovery of misfolded sRNase A (38) . The refolding of denatured and reduced RNase A by using the DsbA͞DsbB oxidizing pathway rapidly adds stable disulfide bonds linking randomly paired cysteines. This addition causes much of the protein to become trapped in inactive (i.e., scrambled) conformations (10) . sRNase A, consisting almost entirely of inactive RNase A, can then be purified from the refolding mixture. Reduced DsbC is able to resolve the incorrect disulfide bonds in sRNase A, thus restoring activity (16, 39) .
The sRNase A alone showed an activity of only 12% that of native RNase A (Fig. 3) . The addition of oxidized DsbC or reduced DsbD␣ separately made no appreciable difference to this background level of activity. The mixture of 2 M reduced DsbD␣ with 2 M oxidized DsbC, however, activated the sRNase A to levels similar to that achieved with 2 M chemically reduced DsbC (72% native RNase A activity), demonstrating that reduction by DsbD␣ activates DsbC.
Complex Formation Between DsbD␣ and DsbC. Having shown that DsbD␣ activates DsbC, we investigated the interaction between these two proteins by examining the formation of mixed disulfide intermediates. Removal of the first cysteine of DsbD␣ (C103) traps the disulfide-exchange reaction as a mixed disulfide intermediate (30, 31) . A similar stable complex was observed when DsbD␣ C103A was mixed with DsbC modified to remove the second active-site cysteine (C101) which might otherwise resolve the mixed-disulfide complex. In these experiments, a 2-fold excess of DsbD␣ was added to DsbC that was incubated under reducing and oxidizing conditions; the products were purified by gel filtration chromatography (Fig. 4) and analyzed by both reducing and nonreducing SDS͞PAGE (Fig. 5) .
Both DsbC and DsbC C101S eluted with an apparent molecular mass of 63 kDa (K av ϭ 0.10) in accordance with the extended conformation of the 46-kDa DsbC dimer. DsbD␣ C103A forms complexes with both DsbC C101S (Fig. 4A ) and oxidized DsbC (Fig. 4B) , as indicated by a shift of the DsbC peak to the higher apparent molecular mass of 70 kDa (K av ϭ 0.08) when DsbD␣ C103A was added under nonreducing conditions. These complexes could be dissociated by the addition of 20 mM DTT, suggesting that they are held together by a disulfide bond (data not shown).
The purified DsbC C101S-DsbD␣ C103A complex showed two bands on reducing SDS͞PAGE (Fig. 5, lanes 4 and 5) . The 26-kDa band corresponds to DsbC C101S, and the 18-kDa band corresponds to DsbD␣ C103A. The ratio of the band intensities is Ϸ2:1. Nonreducing SDS͞PAGE also revealed two bands (Fig.  5, lanes 8 and 9) . The lower of these bands (26 kDa) corresponds to DsbC C101S; the higher molecular mass DTT-sensitive band matches the expected molecular mass of the DsbC C101S-DsbD␣ C103A disulfide-linked complex (44 kDa ϭ 26 kDa ϩ 18 kDa). Denaturation of the disulfide-linked complex under nonreducing conditions produces both molecules composing DsbC monomers disulfide-linked to DsbD␣ and also uncomplexed DsbC monomers in approximately equal amounts.
We estimate the stoichiometry of the DsbC-DsbD␣ complex to be 2:1, based on the sizing column apparent molecular mass (70 kDa) and the results of the reducing and nonreducing gels. This estimate corresponds to a complex of a dimeric DsbC molecule bound to a single DsbD␣ molecule. Similar results were obtained when DsbC C101S was incubated with increasing amounts of DsbD␣ C103A (data not shown). No evidence was The lack of binding to the isolated DsbC thioredoxin domain, even under oxidizing conditions, suggests that the DsbC Nterminal domain is essential for the interaction between these two proteins.
Discussion
Periplasmic disulfide-bond formation requires both highly specific and nonspecific protein interactions mediated by mixed disulfide-bond intermediates. The electron-transport interaction between DsbC and its reductant DsbD occurs in an oxidizing environment and is likely to be highly specific and insulated from the numerous disulfide bonds in the periplasm. DsbD should be able to distinguish between the active-site disulfide bonds of substrates such as DsbC and DsbG and other disulfides within the periplasm. By contrast, the substrate-binding interactions of DsbC are sufficiently nonspecific to allow the successful periplasmic expression of recombinant nonbacterial proteins containing multiple disulfide bonds (40) (41) (42) (43) (44) . We are interested in learning how DsbC participates in these very different types of interaction.
In this work, we have used purified proteins together with disulfide-bond formation and isomerase assays to investigate the interaction between DsbC and DsbD. First, we expressed and purified DsbD␣ and then used gel filtration and DTT reduction to show that both DsbD␣ and DsbD␣ C103A are monomers with solvent-accessible cysteines. The stability and solubility of DsbD␣ and DsbD␣ C103A indicate that these domains are folded.
The results of experiments involving sulfhydryl labeling of mixtures of purified DsbC and DsbD␣ in defined redox states together with protein disulfide-bond isomerase assays showed that DsbD␣ can reduce and fully activate oxidized DsbC. These results are consistent with those of Katzen and Beckwith (30) , who presented in vivo evidence that DsbD␣ interacts directly with DsbC. The results also demonstrate that no other periplasmic components are required to maintain DsbC in the functional reduced state. There was no evidence for the reverse reaction, and no disulfide-bond transfer was observed in mixtures of oxidized DsbD␣ and reduced native DsbC. Complex formation could be seen by using the cysteine mutant DsbD␣ C103A, as observed earlier in vivo (30) . The absence of an observable mixed disulfide intermediate between DsbD␣ and native DsbC after trapping with TCA suggests that the exchange of disulfide bonds from DsbC to DsbD␣ is rapid. Complex formation was observed with both native DsbC and DsbC C101S, the latter presumably a result of oxidation by air. Analysis by gel filtration of the mixed disulfide complex formed between DsbD␣ C103A and DsbC C101S showed that a single DsbD␣ molecule bound a DsbC dimer. No complex formation was observed when the thioredoxin domain of DsbC alone was substituted for full-length DsbC in these experiments. This result implies that regions of DsbC distant from the active site are required for complex formation to occur. For this reason, it is unlikely that the reaction is simply a consequence of the comparative active-site redox potentials of DsbC and DsbD␣.
Many questions remain about the interaction of DsbD and DsbC. We envisage the interaction surface between the DsbD␣ monomer and the DsbC dimer as including the disulfide bond at either one of the two DsbC active sites and extending beyond the DsbC thioredoxin domain, possibly to include parts of both thioredoxin domains. Docking of the two molecules is followed by the formation of a mixed disulfide bond between one of the two DsbC active-site C98 residues and C109 from the DsbD␣ monomer. After transfer of electrons from DsbD and formation of the DsbD C109-C103 disulfide bond, conformational changes occur in one or both partners, causing the complex to disassemble.
What determines the specificity of the DsbD␣-DsbC interaction? How is the reduced DsbD active site protected from other disulfide bonds in the periplasm? The answers to these questions will clearly require detailed information on binding kinetics together with more three-dimensional structures. The observation that single-cysteine mutants of DsbD␣ are prone to degradation within the cell (30) leads us to speculate that the reduced DsbD␣ active site may be locally unfolded. We hypothesize that this locally unfolded conformation mimics the binding of unfolded substrate proteins to DsbC, which is thought to occur at the large, uncharged cleft between the two active sites (32, 39) . Electron transfer and the subsequent formation of the DsbD␣ active-site disulfide bond would then cause a local transition to a more folded, less hydrophobic structure and release DsbD␣ from the DsbC binding cleft. According to this hypothesis, reduced DsbD␣ would be protected from disulfide bonds in nonhydrophobic environments such as those in folded proteins. Specificity of the DsbC-DsbD␣ interaction could be accounted for by the ability of DsbC to bind unfolded substrates, and more importantly, by the redox-coupled local conformational change in DsbD␣, allowing only the reduced molecule to bind to DsbC. Further protein crystallographic structural investigations of DsbD␣, DsbD␣ C103A, and the DsbC-DsbD␣ complex may shed light on the proposed DsbD␣ active-site structural transition. 5 . Analysis of DsbC C101S-DsbD␣ C103A complex formation. DsbC C101S and DsbD␣ C103A were mixed in the presence or absence of either 20 mM DTT or 20 mM GSSG and separated by size-exclusion chromatography (Fig.  4A) . The first eluted peak in each experiment was analyzed by both reducing (lanes 3-5) and nonreducing (lanes 7-9) SDS͞PAGE. A DTT-sensitive band in peak fractions (Fig. 4A, peak X) corresponding to the disulfide-linked complex between DsbC C101S and DsbD␣ C103A is evident by nonreducing SDS͞PAGE (upper band in lanes 8 and 9). Free DsbC C101S is also visible after complex formation (lower band in lanes 8 and 9). The disulfide-linked complex is not visible after separation by reducing SDS͞PAGE (lanes 4 and 5) . The ratio of DsbC C101S to DsbD␣ C103A in the complex peak, which was purified by size-exclusion chromatography and analyzed by reducing SDS͞PAGE, is Ϸ2:1 (lanes 4 and 5). Complex formation is evident in the presence (lanes 5 and 9) or absence (lanes 4 and 8) of 20 mM GSSG. No complex formation is observed when the proteins are mixed in the presence of 20 mM DTT (lanes 3 and 7; the first eluted peak is DsbC C101S). Molecular mass markers are shown in lanes 1 and 6. Lane 2 is DsbD␣ C103A. Markers and DsbD␣ C103A were run under reducing conditions.
